By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Bad News for Evidence-Based Medicine
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Bad News for Evidence-Based Medicine
BusinessTechnology

Bad News for Evidence-Based Medicine

JohnCGoodman
JohnCGoodman
Share
1 Min Read
SHARE

Bruce Booth, a venture capitalist explains the perils of investing in companies whose products are based on scientific discoveries published in academic journals.

Bruce Booth, a venture capitalist explains the perils of investing in companies whose products are based on scientific discoveries published in academic journals.

The unspoken rule is that at least 50% of the studies published even in top tier academic journals – Science, Nature, Cell, PNAS, etc… – can’t be repeated with the same conclusions by an industrial lab. In particular, key animal models often don’t reproduce.  This 50% failure rate isn’t a data free assertion: it’s backed up by dozens of experienced R&D professionals who’ve participated in the (re)testing of academic findings. This is a huge problem for translational research and one that won’t go away until we address it head on.

Competition for grants and careers that depend on published research often tempt academic researchers to manipulate their experiments. The data from these experiments are often sold to Biotech companies who try to commercialize the discovery made in academic laboratories. The biotech’s industrial scientists find they cannot reproduce the experiments and get the same results.

More Read

New Regulation Threatens Agents, HSA Plans
Patient-Centered Physicians Have Lower Diagnostic Testing Costs
Synthetic Cartilage Implant Designed to Restore Natural Joint Mechanics
Hospital Capacity Management: Interview With GE Performance Solutions (transcript)
Health Policy: Stunning Results from California
   

TAGGED:Biotechnologyevidence-based medicine
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

mHealth Patient Care
OrthopaedicsTechnology

Biologics in Spine Surgery

July 19, 2011

Entering a New Era for Clinical Computing and Patient Engagement

August 12, 2013
10-year, Health Care Reserve Fund Enacted
BusinessHospital AdministrationMedical InnovationsNewsTechnology

3 Ways that Crowdfunding Can Benefit the Healthcare Market

April 12, 2012
Ebola
BusinessNewsPublic Health

The Technology Corner: 3 Companies That Could Eradicate Ebola Virus

April 25, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?